Sotera Health EBITDA Margin 2019-2024 | SHC
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Sotera Health (SHC) over the last 10 years. The current EBITDA margin for Sotera Health as of June 30, 2024 is .
| Sotera Health EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2024-06-30 | $1.10B | $0.48B | 43.62% |
| 2024-03-31 | $1.08B | $0.47B | 43.22% |
| 2023-12-31 | $1.05B | $0.44B | 42.33% |
| 2023-09-30 | $0.99B | $0.41B | 40.87% |
| 2023-06-30 | $0.98B | $0.39B | 39.82% |
| 2023-03-31 | $0.99B | $0.39B | 39.84% |
| 2022-12-31 | $1.01B | $0.41B | 40.80% |
| 2022-09-30 | $0.99B | $0.41B | 41.05% |
| 2022-06-30 | $0.97B | $0.41B | 42.43% |
| 2022-03-31 | $0.96B | $0.42B | 43.83% |
| 2021-12-31 | $0.93B | $0.41B | 44.47% |
| 2021-09-30 | $0.91B | $0.40B | 44.10% |
| 2021-06-30 | $0.88B | $0.38B | 43.25% |
| 2021-03-31 | $0.84B | $0.36B | 43.23% |
| 2020-12-31 | $0.82B | $0.36B | 44.25% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $4.699B | $1.049B |
| Sotera Health Company is a provider of mission-critical end-to-end sterilization solutions and lab testing as well as advisory services for the healthcare industry. The company market through businesses which include Sterigenics(R), Nordion(R) and Nelson Labs(R). Sotera Health Company is Sotera Health Company is based in CLEVELAND. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $120.646B | 14.71 |
| Cencora (COR) | United States | $44.115B | 16.86 |
| ICON (ICLR) | Ireland | $23.604B | 21.21 |
| DiDi Global (DIDIY) | China | $22.358B | 0.00 |
| Avantor (AVTR) | United States | $17.717B | 26.87 |
| Revvity (RVTY) | United States | $15.582B | 27.29 |
| Natera (NTRA) | United States | $15.318B | 0.00 |
| Viatris (VTRS) | United States | $13.869B | 4.23 |
| CochLear (CHEOY) | Australia | $12.838B | 0.00 |
| Solventum (SOLV) | United States | $11.762B | 0.00 |
| Charles River Laboratories (CRL) | United States | $10.236B | 19.34 |
| Medpace Holdings (MEDP) | United States | $10.115B | 30.69 |
| Sonic Healthcare (SKHHY) | Australia | $9.094B | 0.00 |
| Doximity (DOCS) | United States | $7.896B | 50.03 |
| HealthEquity (HQY) | United States | $6.867B | 37.27 |
| Bausch + Lomb (BLCO) | Canada | $6.703B | 28.85 |
| PACS (PACS) | United States | $6.038B | 0.00 |
| Organon (OGN) | United States | $4.936B | 5.02 |
| Life Times (LTH) | United States | $4.869B | 40.70 |
| Surgery Partners (SGRY) | United States | $4.095B | 45.37 |
| Concentras Parent (CON) | United States | $2.871B | 0.00 |
| Ardent Health Partners (ARDT) | United States | $2.727B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $2.542B | 95.71 |
| BrightSpring Health Services (BTSG) | United States | $2.524B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $2.127B | 0.00 |
| Premier (PINC) | United States | $1.989B | 8.94 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.961B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $1.620B | 8.14 |
| CareDx (CDNA) | United States | $1.572B | 0.00 |
| Agilon Health (AGL) | United States | $1.535B | 0.00 |
| Progyny (PGNY) | United States | $1.509B | 26.54 |
| Teladoc Health (TDOC) | United States | $1.440B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.151B | 0.00 | |
| QDM (QDMI) | Hong Kong, SAR China | $1.123B | 29.39 |
| GeneDx Holdings (WGS) | United States | $1.094B | 0.00 |
| Pediatrix Medical (MD) | United States | $0.975B | 10.62 |
| Embecta (EMBC) | United States | $0.838B | 5.59 |
| InnovAge Holding (INNV) | United States | $0.774B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.543B | 0.00 |
| Sharecare (SHCR) | United States | $0.528B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.473B | 0.00 |
| Enhabit (EHAB) | United States | $0.399B | 34.48 |
| Sonida Senior Living (SNDA) | United States | $0.374B | 0.00 |
| DocGo (DCGO) | United States | $0.342B | 12.85 |
| Sera Prognostics (SERA) | United States | $0.247B | 0.00 |
| Biodesix (BDSX) | United States | $0.247B | 0.00 |
| LifeMD (LFMD) | United States | $0.224B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.188B | 0.00 |
| ModivCare (MODV) | United States | $0.173B | 5.48 |
| Beauty Health (SKIN) | United States | $0.170B | 0.00 |
| MultiPlan (MPLN) | United States | $0.127B | 0.00 |
| Nutex Health (NUTX) | United States | $0.094B | 0.00 |
| Harvard Apparatus Regenerative Technology (HRGN) | United States | $0.088B | 0.00 |
| So-Young (SY) | China | $0.086B | 20.75 |
| SBC Medicals (SBC) | United States | $0.048B | 0.00 |
| NeueHealth (NEUE) | United States | $0.042B | 1.67 |
| OncoCyte (OCX) | United States | $0.040B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.039B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.037B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.033B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.030B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.028B | 0.00 |
| Oncology Institute (TOI) | United States | $0.023B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.017B | 0.00 |
| XWELL (XWEL) | United States | $0.009B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.008B | 0.00 | |
| KindlyMD (KDLY) | $0.007B | 0.00 | |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.001B | 0.00 |